CVI Holdings’s Redhill Biopharma RDHL Stock Holding History

CVI Holdings’s Portfolio RDHL Stock Details RDHL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-22	Closed	-$198K	–	49
2018 Q3	$198K	Buy	+22	New	+$179K	0.33%	22

Other funds holding RDHL

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Ibex Investors Denver, Colorado $152M AUM 19.17% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

Menta Capital San Francisco, California $236M AUM 6.6% 1-Year Est. Return

CVI Holdings's RDHL Position: Q4 2018 in Review

CVI Holdings sold out of Redhill Biopharma (RDHL) in Q4 2018, closing a stake of 22 shares — an estimated $198K sold.

CVI Holdings first reported a position in RDHL in Q3 2018 and held it in 1 quarter. The position peaked at $198K in Q3 2018. 36 funds tracked by Wall St. Rank hold RDHL as of Q4 2018.

CVI Holdings reported no remaining Redhill Biopharma position as of Q4 2018 after selling out during the quarter.
CVI Holdings sold 22 Redhill Biopharma shares in Q4 2018, an estimated $198K.
CVI Holdings first reported a position in Redhill Biopharma in Q3 2018 and held it in 1 quarter.
CVI Holdings's Redhill Biopharma position peaked at $198K in Q3 2018.
36 funds tracked by Wall St. Rank held Redhill Biopharma as of Q4 2018.

Based on CVI Holdings's 13F filing for Q4 2018, filed 14 Feb 2019.